Lots of interesting abstracts and cases were submitted for TCTAP 2026. Below are the accepted ones after a thorough review by our official reviewers. Don’t miss the opportunity to expand your knowledge!
ABS20251006_0002
The Usefulness of the Geriatric Nutritional Risk Index for Assessing Outcomes in Lower Extremity Artery Disease Following Endovascular Therapy
By Akinori Satake, Hirofumi Ohashi, Hiroaki Sawada, Takahiro Tokuda, Masahiro Shimoda, Akihiro Suzuki, Hiroshi Takahashi, Akio Kodama, Tetsuya Amano
Presenter
Akinori Satake
Authors
Akinori Satake1, Hirofumi Ohashi2, Hiroaki Sawada1, Takahiro Tokuda3, Masahiro Shimoda2, Akihiro Suzuki2, Hiroshi Takahashi4, Akio Kodama2, Tetsuya Amano2
Affiliation
Narita Memorial Hospital, Japan1, Aichi Medical University, Japan2, Nagoya Heart Center, Japan3, Fujita Health University School of Medicine, Japan4
View Study Report
ABS20251006_0002
Other Endovascular Interventions
The Usefulness of the Geriatric Nutritional Risk Index for Assessing Outcomes in Lower Extremity Artery Disease Following Endovascular Therapy
Akinori Satake1, Hirofumi Ohashi2, Hiroaki Sawada1, Takahiro Tokuda3, Masahiro Shimoda2, Akihiro Suzuki2, Hiroshi Takahashi4, Akio Kodama2, Tetsuya Amano2
Narita Memorial Hospital, Japan1, Aichi Medical University, Japan2, Nagoya Heart Center, Japan3, Fujita Health University School of Medicine, Japan4
Background
Lower extremity artery disease (LEAD) is acommon disease associated with a higher risk of amputation and death. TheGeriatric Nutritional Risk Index (GNRI) is a useful marker for assessingnutritional status; however, its relationship with outcomes in patients with LEAD followingendovascular therapy (EVT) remains unclear.
Methods
Between April 2010 and December 2022, we included 127 patients who underwent initial EVT. Patients were divided into two groups based on a GNRI of 92. The primary endpoint was all-cause mortality, and the secondary endpoint was major amputation after EVT.
Results
The median follow-up period was 47.5 months (interquartile range: 34.0–61.8 months). All-cause mortality and major amputation were significantly higher in the lower GNRI group (log–rank p < 0.01). A GNRI was independently associated with all-cause mortality after EVT (hazard ratio: 0.95, 95% confidence interval: 0.92–0.97, p < 0.01). In addition, in the claudication group, all-cause mortality and major amputation were also significantly higher in the lower GNRI group (log–rank p = 0.01, log–rank p = 0.02, respectively).
Conclusion
All-cause mortality and major amputation were significantly higher in the lower GNRI group after EVT. Moreover, in the claudication group, all-cause mortality and major amputation were also significantly higher in the lower GNRI group. These findings highlight the importance of addressing nutritional status in the early stages of LEAD to improve clinical outcomes.